Navigation Links
FDA's Rick Friedman and Rebecca Rodriguez Confirmed as Closing Plenary Speakers for PDA Human Factors Workshop
Date:2/26/2013

BETHESDA, Md., Feb. 26 2013 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that Richard Friedman , Associate Director OMPQ, U.S. FDA, and Rebecca Rodriguez , Consumer Safety Officer, U.S. FDA, have been confirmed to deliver the closing plenary talks at the 2013 Human Factors and Human Error Reduction Workshop. The workshop will take place on April 17 – 18, 2013 at the Peabody Hotel in Orlando, Fla.

(Logo: http://photos.prnewswire.com/prnh/20130226/DC66667LOGO)  

"PDA continues Connecting People, Science and Regulation® by offering high-quality, technical workshops with the cooperation of officials from the FDA and other regulatory bodies worldwide," said Richard Johnson , PDA President and CEO. "In 2013, we are hosting seven conferences and workshops with the FDA on topics critical to pharmaceutical manufacturers, like glass packaging, supply chain and internal investigations. The 22nd annual PDA/FDA Joint Regulatory Conference stands out as the longest running, co-hosted meeting with FDA on GMP and other QA/QC and manufacturing topics. In addition, FDA officials like Mr. Friedman and Ms. Rodriguez continue to participate in our other meetings, like the Human Factors Workshop and the Annual Meeting."

The workshop will introduce the audience to the science of human factors and will illustrate the significant role and impact human factors has made in other industries ranging from aviation to nuclear control rooms. Following this brief introduction, the audience will participate in interactive sessions to learn how to use various human factors tools to help assess, understand and utilize the information needed to address manufacturing performance and/or safety concerns in processing and manufacturing facilities. 

Friedman and Rodriguez serve as the closing bookend to an event that begins with Keynote Speaker Dr. Najmedin Meshkati , Prof. of Civil/Environmental Engineering and Industrial Systems Engineering at the Viterbi School of Engineering, University of Southern California. In between, sessions featuring case studies will be shared by the moderators to highlight potential areas of concern, and how these areas have been improved through the use of human factors tools and techniques, resulting in improvements of operations, layout, workflow and overall system design. Speakers from Amgen, Radius Product Development and Abbott Medical Optics are already confirmed.

More information on the workshop is available at http://www.pda.org/humanfactors2013.

About PDA:
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide.

Media Inquiries: Walt Morris , 301-656-5900; morris@pda.org


'/>"/>
SOURCE Parenteral Drug Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gliknik Adds Incyte President & CEO Paul A. Friedman to its Board of Directors
2. RxAlly Adds Accomplished Clinical Services Expert And Pharmacist, Rebecca Chater, To The Companys Leadership Team
3. BD Board of Directors Elects Rebecca W. Rimel
4. High-Flo™ Confirmed As "Safety Sets"
5. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
6. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
7. Echo Therapeutics Announces Closing of Public Offering of Common Stock
8. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
9. Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement
10. Winner Medical Announces Closing of Going Private Transaction
11. Trovagene Announces Closing of Private Placement of $3.76 Million from the Sale of Restricted Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):